Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 15307-79-6 | Product Number: D2508
Diclofenac Sodium Salt
Purity: >98.0%(HPLC)(qNMR)
- 2-(2,6-Dichloroanilino)phenylacetic Acid Sodium Salt
- Sodium 2-(2,6-Dichloroanilino)phenylacetate
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | D2508 |
Purity / Analysis Method
|
>98.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C__1__4H__1__0Cl__2NNaO__2 = 318.13 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 15307-79-6 |
Related CAS RN
|
15307-86-5 |
| Reaxys Registry Number | 3581138 |
| PubChem Substance ID | 87568933 |
| Merck Index (14) | 3081 |
| MDL Number | MFCD00082251 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(qNMR) | min. 98.0 % |
| Solubility in Methanol | almost transparency |
| NMR | confirm to structure |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. |
| EC Number | 239-346-4 |
| RTECS# | AG6330000 |
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| HS Number | 2922498590 |
Reference
- ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid
References
- Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy (a review)
- On the use of the Weibull function for the discernment of drug release mechanisms
- Formulation optimization of controlled release diclofenac sodium microspheres using factorial design
- Preparation and characterization of a novel pH-sensitive chitosan-g-poly (acrylic acid)/attapulgite/sodium alginate composite hydrogel bead for controlled release of diclofenac sodium
- The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target (a review)
- Diclofenac sodium (a review on the preparation, physical properties, stability, toxicity, and analytical methods for detection of diclofenac sodium)
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.